Aberrant phosphorylation of STAT5 by granulocyte-macrophage colony-stimulating factor in infant cytomegalovirus infection mimicking juvenile myelomonocytic leukemia

Leukemia Research

Volumn 35, Issue 9, 2011, Pages 1261-1264

  Nishio, Nobuhiro ^a   Takahashi, Yoshiyuki ^a   Tanaka, Makito ^a   Xu, Yinyan ^a   Yoshida, Nao ^a   Sakaguchi, Hirotoshi ^a   Doisaki, Sayoko ^a   Hama, Asahito ^a   Muramatsu, Hideki ^a   Shimada, Akira ^a   Kojima, Seiji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytomegalovirus infection; JMML; STAT5

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STAT5 PROTEIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFANT; JUVENILE MYELOMONOCYTIC LEUKEMIA; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; DIAGNOSIS, DIFFERENTIAL; EFFICIENCY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFANT; LEUKEMIA, MYELOMONOCYTIC, JUVENILE; MALE; PHOSPHORYLATION; SENSITIVITY AND SPECIFICITY; STAT5 TRANSCRIPTION FACTOR;

EID: 80051474493     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.04.014     Document Type: Article

References (8)

1. Emanuel P.D., Bates L.J., Castleberry R.P., Gualtieri R.J., Zuckerman K.S. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 1991, 77:925-929.
2. Tanaka M., Takahashi Y., Xu Y., Yoshida N., Yoshimi A., Villalobos I.B., et al. Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by 3H-thymidine assay. Leukemia Research 2008, 32:1036-1042.
3. Kotecha N., Flores N.J., Irish J.M., Simonds E.F., Sakai D.S., Archambeault S., et al. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer cell 2008, 14:335-343.
4. Niemeyer C.M., Fenu S., Hasle H., Mann G., Stary J., Wering E. Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood 1998, 91:365-367.
5. Moritake H., Ikeda T., Manabe A., Kamimura S., Nunoi H. Cytomegalovirus infection mimicking juvenile myelomonocytic leukemia showing hypersensitivity to granulocyte-macrophage colony stimulating factor. Pediatric Blood & Cancer 2009, 53:1324-1326.
6. Gaipa G., Bugarin C., Longoni D., Cesana S., Molteni C., Faini A., et al. Aberrant GM-CSF signal transduction pathway in juvenile myelomonocytic leukemia assayed by flow cytometric intracellular STAT5 phosphorylation measurement. Leukemia 2009, 23:791-793.
7. Toyoda H., Ido M., Hori H., Hiraiwa H., Hirayama M., Kobayashi M., et al. A case of juvenile myelomonocytic leukemia with concomitant cytomegalovirus infection. Journal of Pediatric Hematology/Oncology 2004, 26:606-608.
8. Manabe A., Yoshimasu T., Ebihara Y., Yagasaki H., Wada M., Ishikawa K., et al. Viral infections in juvenile myelomonocytic leukemia: prevalence and clinical implications. Journal of Pediatric Hematology/Oncology 2004, 26:636-641.